Publications by authors named "Nadir Cheurfa"

Claim this Profile
A
Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.
Joël Guigay, Hervé Le Caer, François-Régis Ferrand, Lionel Geoffrois, Esma Saada-Bouzid, Nadir Cheurfa

Lancet Healthy Longev· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
Joël Guigay, Cécile Ortholan, Damien Vansteene, Didier Cupissol, Caroline Even, Nadir Cheurfa

Lancet Healthy Longev· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results of methotrexate-etoposide-ifosfamide based regimen (M-EI) in osteosarcoma patients included in the French OS2006/sarcome-09 study.
Nathalie Gaspar, Bob-Valéry Occean, Hélène Pacquement, Emmanuelle Bompas, Corine Bouvier, Nadir Cheurfa

Eur J Cancer· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allelic variations in the vitamin D receptor gene, insulin secretion and parents' heights are independently associated with height in obese children and adolescents.
Daniela A F Ferrarezi, Naïma Bellili-Muñoz, Christiane Nicolau, Nadir Cheurfa, Isabel C Guazzelli

Metabolism· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome.
André F Reis, Caroline Kannengiesser, Farida Jennane, Thais Della Manna, Nadir Cheurfa

Pediatr Diabetes· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The common -866G>A variant in the promoter of UCP2 is associated with decreased risk of coronary artery disease in type 2 diabetic men.
Nadir Cheurfa, Danièle Dubois-Laforgue, Daniela A F Ferrarezi, André F Reis, Guilherme M Brenner

Diabetes· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adiponectin gene and cardiovascular risk in type 2 diabetic patients: a review of evidences.
Daniela A F Ferrarezi, Nadir Cheurfa, André F Reis, Frédéric Fumeron, Gilberto Velho

Arq Bras Endocrinol Metabol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis